Frontiers in Psychiatry | Psychopharmacology

Original Research

Published on 10 Feb 2022

Improving Mood and Cognitive Symptoms in Huntington's Disease With Cariprazine Treatment

in Psychopharmacology

Maria Judit Molnar
Viktor Molnar
Mariann Fedor
Reka Csehi
Karoly Acsai
Beata Borsos
Zoltan Grosz

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.825532

5,690 views
18 citations

Editorial

Published on 08 Feb 2022

Editorial: Gone to Pot: Examining the Association Between Cannabis Use and Medical/Psychiatric Disorders

in Psychopharmacology

Rajiv Radhakrishnan
Sinan Guloksuz
Deepak C. D'Souza
Jim van Os

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.837757

3,146 views

Original Research

Published on 08 Feb 2022

Bumetanide for Irritability in Children With Sensory Processing Problems Across Neurodevelopmental Disorders: A Pilot Randomized Controlled Trial

in Psychopharmacology

Dorinde M. van Andel
Jan J. Sprengers
Mandy G. Keijzer-Veen
Annelien J. A. Schulp
Marc R. Lillien
Floortje E. Scheepers
Hilgo Bruining

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.780281

6,477 views
8 citations

Review

Published on 03 Feb 2022

Dopamine in Autism Spectrum Disorders—Focus on D2/D3 Partial Agonists and Their Possible Use in Treatment

in Psychopharmacology

Vanja Mandic-Maravic
Roberto Grujicic
Luka Milutinovic
Ana Munjiza-Jovanovic
Milica Pejovic-Milovancevic

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.787097

38,774 views
49 citations

Original Research

Published on 27 Jan 2022

Activity-State Dependent Reversal of Ketamine-Induced Resting State EEG Effects by Clozapine and Naltrexone in the Freely Moving Rat

in Psychopharmacology

Christien Bowman
Ulrike Richter
Christopher R. Jones
Claus Agerskov
Kjartan Frisch Herrik

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.737295

5,568 views
6 citations

Review

Published on 25 Jan 2022

Dopamine Receptor Partial Agonists: Do They Differ in Their Clinical Efficacy?

in Psychopharmacology

Pavel Mohr
Jirí Masopust
Miloslav Kopeček

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.781946

35,941 views
29 citations

Original Research

Published on 24 Jan 2022

Early Clinical Effects of Novel Partial D3/D2 Agonist Cariprazine in Schizophrenia Patients With Predominantly Negative Symptoms (Open-Label, Non-controlled Study)

in Psychopharmacology

Stanislav V. Ivanov
Anatoly B. Smulevich
Evgeniya I. Voronova
Kausar K. Yakhin
Tangyul Z. Beybalaeva
Alena A. Katok

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.770592

2,727 views
8 citations

Original Research

Published on 24 Jan 2022

Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database

in Psychopharmacology

Tigran Makunts
Lisa Jerome
Ruben Abagyan
Alberdina de Boer

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.824288

39,115 views
14 citations

Original Research

Published on 19 Jan 2022

The Cognitive-Enhancing Effects of Dendrobium nobile Lindl Extract in Sleep Deprivation-Induced Amnesic Mice

in Psychopharmacology

Ning Jiang
Yu-jiao Li
Meng-di Wang
Hong Huang
Shanguang Chen
Yinghui Li
Lina Qu
Fengzhong Wang
Xinmin Liu
Qiong Wang

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.596017

3,954 views
8 citations

Case Report

Published on 12 Jan 2022

A Cohort-Based Case Report: The Impact of Ketamine-Assisted Therapy Embedded in a Community of Practice Framework for Healthcare Providers With PTSD and Depression

in Psychopharmacology

Shannon Dames
Pamela Kryskow
Crosbie Watler

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.803279

21,677 views
19 citations

Original Research

Published on 12 Jan 2022

Effects of Acceptance and Commitment Therapy and Repetitive Transcranial Magnetic Stimulation on Obsessive–Compulsive Disorder

in Psychopharmacology

Jingzhi Zou
Siliang Wu
Xin Yuan
Zhizhong Hu
Jun Tang
Maorong Hu

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.720518

5,105 views
7 citations

Original Research

Published on 12 Jan 2022

Preferential Effects of Cariprazine on Counteracting the Disruption of Social Interaction and Decrease in Extracellular Dopamine Levels Induced by the Dopamine D3 Receptor Agonist, PD-128907 in Rats: Implications for the Treatment of Negative and Depressive Symptoms of Psychiatric Disorders

in Psychopharmacology

Jan Kehr
Fu-Hua Wang
Fumio Ichinose
Shimako Yoshitake
Bence Farkas
Béla Kiss
Nika Adham

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.801641

4,960 views
4 citations

Perspective

Published on 05 Jan 2022

Dosing Cariprazine Within and Beyond Clinical Trials: Recommendations for the Treatment of Schizophrenia

in Psychopharmacology

Elmars Rancans
Zsófia Borbála Dombi
Ágota Barabássy

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.770234

12,116 views
13 citations

Review

Published on 03 Jan 2022

Primary and Secondary Negative Symptoms in Schizophrenia

in Psychopharmacology

Sergey N. Mosolov
Polina A. Yaltonskaya

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.766692

69,823 views
75 citations

Correction

Published on 21 Dec 2021

Corrigendum: Risk of Bleeding Associated With Antidepressants: Impact of Causality Assessment and Competition Bias on Signal Detection

in Psychopharmacology

René Zeiss
Bernhard J. Connemann
Carlos Schönfeldt-Lecuona
Maximilian Gahr

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.813879

1,290 views
1 citation

Review

Published on 17 Dec 2021

Protective Effects and Mechanism of Radix Polygalae Against Neurological Diseases as Well as Effective Substance

in Psychopharmacology

Ning Jiang
Shanshan Wei
Yiwen Zhang
Wenlu He
Haiyue Pei
Hong Huang
Qiong Wang
Xinmin Liu

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.688703

11,684 views
24 citations